A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dow Pharmaceutical Sciences

Criteria

Inclusion Criteria:

• Presence of facial rosacea

• Presence of inflammatory lesions

Exclusion Criteria:

• Dermatological conditions of the face that could interfere with clinical evaluations

• Known history of photosensitivity disorders (such as lupus erythematosus or polymorphous light eruption)

• Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study